Literature DB >> 35249184

Very late onset AChR-myasthenia gravis with tongue atrophy.

Vasiliki Zouvelou1, Georgios Zorbas2, Eleni Strataki2, Efstratios Karavasilis3, Georgios Velonakis3.   

Abstract

Entities:  

Keywords:  AChR; Atrophy; MRI; MuSK; Myasthenia gravis; Tongue

Mesh：

Substances：

Year:  2022        PMID： 35249184     DOI： 10.1007/s13760-022-01900-9

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.471


× No keyword cloud information.
  4 in total

Review 1.  Myasthenia Gravis.

Authors:  Daniel B Drachman
Journal:  Semin Neurol       Date:  2016-09-23       Impact factor: 3.420

2.  MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.

Authors:  Olivier Benveniste; Leslie Jacobson; Maria Elena Farrugia; Linda Clover; Angela Vincent
Journal:  J Neuroimmunol       Date:  2005-10-06       Impact factor: 3.478

3.  MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

Authors:  Maria Elena Farrugia; Matthew D Robson; Linda Clover; Phil Anslow; John Newsom-Davis; Robin Kennett; David Hilton-Jones; Paul M Matthews; Angela Vincent
Journal:  Brain       Date:  2006-05-03       Impact factor: 13.501

4.  Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.

Authors:  Elena Cortés-Vicente; Rodrigo Álvarez-Velasco; Sonia Segovia; Carmen Paradas; Carlos Casasnovas; Antonio Guerrero-Sola; Julio Pardo; Alba Ramos-Fransi; Teresa Sevilla; Adolfo López de Munain; Maria Teresa Gómez; Ivonne Jericó; Gerardo Gutiérrez-Gutiérrez; Ana Lara Pelayo-Negro; María Asunción Martín; María Dolores Mendoza; Germán Morís; Ricard Rojas-Garcia; Jordi Díaz-Manera; Luis Querol; Eduard Gallardo; Beatriz Vélez; María Antonia Albertí; Lucía Galán; Tania García-Sobrino; Alicia Martínez-Piñeiro; Ana Lozano-Veintimilla; Roberto Fernández-Torrón; Ángel Cano-Abascal; Isabel Illa
Journal:  Neurology       Date:  2020-02-18       Impact factor: 9.910
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.